Long-lasting tumor response on short-time administration of vemurafenib—A case report

por Mitzel, Heidrun, Grabbe, Stephan, Loquai, Carmen
Publicado 2014

Acute low back pain as infusion-related reaction to monoclonal antibodies

por Majenka, Pawel, Loquai, Carmen, Schöning, Tilman, Enk, Alexander, Hassel, Jessica
Publicado 2023

The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma—A Retrospe...

por Haist, Maximilian, Stege, Henner, Ebner, Ronja, Fleischer, Maria Isabel, Loquai, Carmen, Grabbe, Stephan
Publicado 2022

Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters

por Schmidberger, Heinz, Rapp, Matthias, Ebersberger, Anne, Hey-Koch, Silla, Loquai, Carmen, Grabbe, Stephan, Mayer, Arnulf
Publicado 2018

Role of Hypoxia and the Adenosine System in Immune Evasion and Prognosis of Patients with Brain Metastases of Melanoma: A Multiplex Whole Slide Immunofluorescence Study

por Mayer, Arnulf, Haist, Maximilian, Loquai, Carmen, Grabbe, Stephan, Rapp, Matthias, Roth, Wilfried, Vaupel, Peter, Schmidberger, Heinz
Publicado 2020

The Status of Adjuvant and Neoadjuvant Melanoma Therapy, New Developments and Upcoming Challenges

por Stege, Henner, Haist, Maximilian, Nikfarjam, Ulrike, Schultheis, Michael, Heinz, Jaqueline, Pemler, Saskia, Loquai, Carmen, Grabbe, Stephan
Publicado 2021

Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivi...

por Gutzmer, Ralf, Robert, Caroline, Loquai, Carmen, Schadendorf, Dirk, Squittieri, Nicholas, Arntz, Ramon, Martelli, Serena, Dummer, Reinhard
Publicado 2021

Screening for Distress in Routine Oncological Care—A Survey in 520 Melanoma Patients

por Loquai, Carmen, Scheurich, Vera, Syring, Nils, Schmidtmann, Irene, Rietz, Stephan, Werner, Andreas, Grabbe, Stephan, Beutel, Manfred E.
Publicado 2013

Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 wee...

por Migden, Michael, Loquai, Carmen, Robert, Caroline, Baurain, Jean-François, Squittieri, Nicholas, Arntz, Ramon, Dierlamm, Jörg, Dréno, Brigitte
Publicado 2022

B-Raf inhibitor vemurafenib in combination with temozolomide and fotemustine in the killing response of malignant melanoma cells

por Roos, Wynand P., Quiros, Steve, Krumm, Andrea, Merz, Stephanie, Switzeny, Olivier Jérôme, Christmann, Markus, Loquai, Carmen, Kaina, Bernd
Publicado 2014

Real-World Use of Talimogene Laherparepvec in German Patients with Stage IIIB to IVM1a Melanoma: A Retrospective Chart Review and Physician Survey

por Mohr, Peter, Haferkamp, Sebastian, Pinter, Andreas, Weishaupt, Carsten, Huber, Margit A., Downey, Gerald, Öhrling, Katarina, Loquai, Carmen, Louie, Karly S.
Publicado 2018

Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Malignant Melanoma Receiving Immune...

por Haist, Maximilian, Stege, Henner, Pemler, Saskia, Heinz, Jaqueline, Fleischer, Maria Isabel, Graf, Claudine, Ruf, Wolfram, Loquai, Carmen, Grabbe, Stephan
Publicado 2021

Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma

por Hassel, Jessica C., Buder‐Bakhaya, Kristina, Bender, Carolin, Zimmer, Lisa, Weide, Benjamin, Loquai, Carmen, Ugurel, Selma, Slynko, Alla, Gutzmer, Ralf
Publicado 2017

Key Clinical Adverse Events in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib or Vismodegib: A Post Hoc Analysis

por Gutzmer, Ralf, Loquai, Carmen, Robert, Caroline, Dréno, Brigitte, Guminski, Alexander, Lewis, Karl, Arntz, Ramon, Martelli, Serena, Squittieri, Nicholas, Kheterpal, Meenal
Publicado 2021

In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PET

por Pektor, Stefanie, Hilscher, Lina, Walzer, Kerstin C., Miederer, Isabelle, Bausbacher, Nicole, Loquai, Carmen, Schreckenberger, Mathias, Sahin, Ugur, Diken, Mustafa, Miederer, Matthias
Publicado 2018

Platelet-Derived GARP Induces Peripheral Regulatory T Cells—Potential Impact on T Cell Suppression in Patients with Melanoma-Associated Thrombocytosis

por Zimmer, Niklas, Krebs, Franziska K., Zimmer, Sophia, Mitzel-Rink, Heidrun, Kumm, Elena J., Jurk, Kerstin, Grabbe, Stephan, Loquai, Carmen, Tuettenberg, Andrea
Publicado 2020

Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma

por Krebs, Franziska K., Trzeciak, Emily R., Zimmer, Sophia, Özistanbullu, Deniz, Mitzel‐Rink, Heidrun, Meissner, Markus, Grabbe, Stephan, Loquai, Carmen, Tuettenberg, Andrea
Publicado 2021

Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study

por Salzmann, Martin, Wald, Alexander, Stege, Henner, Loquai, Carmen, Zimmer, Lisa, Hayani, Kinan M., Heinzerling, Lucie, Gutzmer, Ralf, Enk, Alexander H., Hassel, Jessica C.
Publicado 2023

Retrospective Analysis of Checkpoint Inhibitor Therapy-Associated Cases of Bullous Pemphigoid From Six German Dermatology Centers

por Sadik, Christian D., Langan, Ewan A., Gutzmer, Ralf, Fleischer, Maria Isabel, Loquai, Carmen, Reinhardt, Lydia, Meier, Friedegund, Göppner, Daniela, Herbst, Rudolf A., Zillikens, Detlef, Terheyden, Patrick
Publicado 2021

Willingness to pay for a cure of low-risk melanoma patients in Germany

por Augustin, Matthias, Blome, Christine, Forschner, Andrea, Gutzmer, Ralf, Hauschild, Axel, Heinzerling, Lucie, Livingstone, Elisabeth, Loquai, Carmen, Schadendorf, Dirk, Utikal, Jochen, Wagner, Tobias, Wilden, Sophia, Kähler, Katharina C.
Publicado 2018